NYSE:BMY   Bristol-Myers Squibb Company
BMY looking to breakout from Jan 2020 run-up. Over all major EMAs. Active Sequence engaged on March 17, 2021 (8 over the 21). Additionally, looking at the Andrew Pitchfork it shows significant respect going back to 1994. Lastly, over the weekly POC from Volume Profile perspective and seems to be breaking out of the range. Initial price targets $70.12 and $77.88.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。